{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:35:32Z","timestamp":1790411732645,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Ministry of Health","award":["FIS PS09\/0673"],"award-info":[{"award-number":["FIS PS09\/0673"]}]},{"name":"Spanish Ministry of Health","award":["FIS PS09\/0665"],"award-info":[{"award-number":["FIS PS09\/0665"]}]},{"name":"Spanish Ministry of Health","award":["FIS PI10\/00387"],"award-info":[{"award-number":["FIS PI10\/00387"]}]},{"name":"Spanish Ministry of Health","award":["RETIC C06\/01 RD06\/0014\/0029"],"award-info":[{"award-number":["RETIC C06\/01 RD06\/0014\/0029"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.atherosclerosis.2012.03.011","type":"journal-article","created":{"date-parts":[[2012,3,17]],"date-time":"2012-03-17T01:33:43Z","timestamp":1331948023000},"page":"449-455","source":"Crossref","is-referenced-by-count":71,"title":["Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia"],"prefix":"10.1016","volume":"222","author":[{"given":"Mar\u00eda","family":"Solanas-Barca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"de Castro-Or\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Mateo-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Cof\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Plana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Puzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Burillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Mart\u00edn-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Masana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Pocov\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Civeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Cenarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/01.mol.0000217890.54875.13","article-title":"Familial combined hyperlipidemia: upstream transcription factor 1 and beyond","volume":"17","author":"Lee","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0010","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.85.6.2025","article-title":"Familial lipoprotein disorders in patients with premature coronary artery disease","volume":"85","author":"Genest","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0015","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/eurheartj\/ehp051","article-title":"Familial-combined hyperlipidaemia in very young myocardial infarction survivors (<40 years of age)","volume":"30","author":"Wiesbauer","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0020","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI107332","article-title":"Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia","volume":"52","author":"Goldstein","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0025","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1194\/jlr.R800081-JLR200","article-title":"New technologies for delineating and characterizing the lipid exome: prospects for understanding familial combined hyperlipidemia","volume":"50","author":"Horswell","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.CIR.0000081777.17879.85","article-title":"Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute family heart study","volume":"108","author":"Hopkins","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0035","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.jacc.2008.06.050","article-title":"Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting","volume":"52","author":"Civeira","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0040","series-title":"The metabolic and molecular bases of inherited disease","first-page":"2835","article-title":"Type III hiperlipoproteinemia (Dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism","author":"Mahley","year":"2001"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0045","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/01.ATV.0000077220.44620.9B","article-title":"Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia","volume":"23","author":"Ayyobi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0050_1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1210\/jc.2006-1973","article-title":"High plasma level of remnant-like particles cholesterol in familial combined hyperlipidemia","volume":"92","author":"de Graaf","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0050_2","first-page":"877","article-title":"Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date","volume":"3","author":"Gaddi","year":"2007","journal-title":"Vasc Health Risk Manage"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0055","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1373\/clinchem.2004.047001","article-title":"Screening for dysbetalipoproteinemia by plasma cholesterol and apolipoprotein B concentrations","volume":"51","author":"Blom","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0060","first-page":"730","article-title":"Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovascular disease in Spain) study. DRECE study group","volume":"113","author":"G\u00f3mez-Gerique","year":"1999","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0065","article-title":"Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia","author":"Jarauta","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0070","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1373\/clinchem.2004.045203","article-title":"Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia","volume":"51","author":"Tejedor","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0075","first-page":"319","article-title":"Polymorphisms of the apolipoprotein B and E genes and their possible roles in familial and non-familial combined hyperlipidaemia","volume":"9","author":"Houlston","year":"1991","journal-title":"Dis Markers"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0021-9150(96)05924-2","article-title":"Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia","volume":"126","author":"Bredie","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0085","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1253\/circj.70.1606","article-title":"Apolipoprotein E polymorphism influences lipid phenotypes in Chinese families with familial combined hyperlipidemia","volume":"70","author":"Pei","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0090","first-page":"268","article-title":"Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation","volume":"37","author":"Sing","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0095","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","article-title":"Association of apolipoprotein E genotypes with lipid levels and coronary risk","volume":"298","author":"Bennet","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MOL.0b013e32833af368","article-title":"Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases","volume":"21","author":"Huang","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.8.1.1","article-title":"Apolipoprotein E polymorphism and atherosclerosis","volume":"8","author":"Davignon","year":"1988","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0021-9150(95)06745-0","article-title":"Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136\u2192Ser) variant in multigenerational pedigree studies","volume":"122","author":"Pocovi","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0115","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI113096","article-title":"Apolipoprotein E2-Christchurch (136 Arg\u2192Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia","volume":"80","author":"Wardell","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0120","first-page":"4354","article-title":"Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149Leu)]","volume":"85","author":"Nguyen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0125","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/sj.ejhg.5201480","article-title":"Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation","volume":"13","author":"Faivre","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0130","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/S0021-9258(18)68957-4","article-title":"Site-specific mutagenesis of human apolipoprotein E","volume":"263","author":"Lalazar","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0135","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0140","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1210\/jc.2009-0814","article-title":"Mutations in HFE causing hemochromatosis are associated with primary hypertriglyceridemia","volume":"94","author":"Solanas-Barca","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2012.03.011_bib0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacl.2011.03.001","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J Clin Lipidol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012001955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012001955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T07:05:53Z","timestamp":1641279953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915012001955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0021915012001955"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.03.011","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}